Co-Diagnostics Inc. Common Stock (NASDAQ: CODX)
The Complaint alleges that during the Class Period, Defendants repeatedly touted the Logix Smart™ COVID-19 Test, reassuring investors about the demand for the product. The Complaint further alleges that, at the same time, Defendants failed to disclose that: (1) demand for the Logix Smart™ COVID-19 Test had plummeted throughout the quarter ended June 30, 2022, and (2) as a result, Defendants’ positive statements about the demand for its Logix Smart™ COVID-19 Test lacked a reasonable basis.